Efficacy of yeast beta-glucan 1,3/1,6 supplementation on respiratory infection, fatigue, immune markers and gut health among moderate stress adults in Klang Valley of Malaysia: protocol for a randomised, double-blinded, placebo-controlled, parallel-group study

作者
Nur Nadia Mohamad Habibullah,Suzana Shahar,Munirah Ismail,Norhayati Ibrahim,Mohd Zul Amin Kamaruddin,Shirley Gee Hoon Tang,Mohd Faisal Abdul Hamid,Kalavathy Ramasamy
出处
期刊:BMJ Open [BMJ]
卷期号:15 (1): e084277-e084277 被引量:6
标识
DOI:10.1136/bmjopen-2024-084277
摘要

INTRODUCTION: Yeast beta-glucan (YBG) are recognised for enhancing the immune system by activating macrophages, a key defence mechanism. Given the global prevalence and impact of upper respiratory tract infections (URTIs) on productivity and healthcare costs, YBG has shown promise as a potential therapeutic and preventive strategy for recurrent respiratory tract infections. However, little is known regarding the efficacy of YBG at lower dosages in relation to URTI, fatigue, immune response and uncertainties of how they affect the gut microbiota composition. METHODS AND ANALYSIS: This 12-week randomised, double-blinded, placebo control, parallel-group clinical trial aims to evaluate the efficacy of YBG 1,3/1,6 on respiratory tract infection, fatigue, immune markers and gut health among adults with moderate stress. The study involves 198 adults aged 18-59 years with moderate stress levels as assessed using Perceived Stress Scale 10 (score 14-26) and Patient Health Questionnaire 9 (score ≥9); and had symptoms of common colds for the past 6 months as assessed using Jackson Cold Scale. These participants will be randomised into three groups, receiving YBG 1,3/1,6 at either 120 mg, 204 mg or a placebo. The outcomes measures include respiratory infection symptoms, fatigue, mood state and quality of life assessed using Wisconsin Upper Respiratory Symptoms Scale, Multidimensional Fatigue Inventory, Profile of Mood State and Short Form 36 Health Survey Questionnaire, respectively. In addition, full blood analysis and assessment of immune, inflammatory and oxidative stress biomarkers will be taken. Secondary outcome includes gut microbiota analysis using stool samples via 16S rRNA sequencing. ETHICS AND DISSEMINATION: The research protocol of the study was reviewed and approved by the Research Ethics Committee of Universiti Kebangsaan Malaysia (UKM/PPI/111/8/JEP-2023-211). The findings will be disseminated to participants, healthcare professionals and researchers via conference presentations and peer-reviewed publications. TRIAL REGISTRATION NUMBER: ISRCTN48336189.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
qearl发布了新的文献求助10
1秒前
Mi完成签到,获得积分10
1秒前
1秒前
单纯草丛完成签到,获得积分10
2秒前
2秒前
2秒前
贪玩的水壶完成签到 ,获得积分10
2秒前
派大星完成签到,获得积分10
2秒前
KIC完成签到,获得积分10
2秒前
酷波er的应助被大力荷花采纳,获得10
2秒前
小阿志完成签到,获得积分10
2秒前
3秒前
完美世界的应助被醉熏的代秋采纳,获得10
3秒前
bz完成签到,获得积分10
3秒前
谨慎初曼完成签到,获得积分10
3秒前
回星予你发布了新的文献求助10
3秒前
4秒前
4秒前
YXL完成签到,获得积分10
4秒前
漂亮的战斗机完成签到 ,获得积分10
4秒前
guoguo发布了新的文献求助10
5秒前
Emma施施完成签到,获得积分10
5秒前
爱撒娇的天磊完成签到,获得积分10
5秒前
5秒前
王哇噻完成签到 ,获得积分10
5秒前
秋风的应助被jinx采纳,获得20
5秒前
Jasper的应助被科研通管家采纳,获得10
5秒前
小二郎的应助被科研通管家采纳,获得10
5秒前
hxhdh的应助被科研通管家采纳,获得20
5秒前
5秒前
5秒前
今后的应助被悦耳十三采纳,获得10
5秒前
Akim的应助被科研通管家采纳,获得10
5秒前
专注的网络完成签到 ,获得积分10
5秒前
SAKURA的应助被科研通管家采纳,获得10
5秒前
充电宝的应助被科研通管家采纳,获得10
6秒前
阳光绿海发布了新的文献求助10
6秒前
星空发布了新的文献求助10
6秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180339
求助须知:如何正确求助?哪些是违规求助? 9570391
关于积分的说明 21811279
捐赠科研通 7776418
什么是DOI,文献DOI怎么找? 3433277
关于科研通互助平台的介绍 2557483
邀请新用户注册赠送积分活动 2479091